Key result
The KardioPro cardiovascular prevention programme reduced the combined risk of all-cause mortality, acute myocardial infarction, and ischemic stroke by 23.5% compared to standard care.
Why the study?
Does the 'KardioPro' cardiovascular prevention programme reduce the composite of all-cause mortality, acute MI, and ischemic stroke in insured adults aged 45+ or with known CHD?
Cohort (n=26,202)
Yes
Does the 'KardioPro' cardiovascular prevention programme reduce the composite of all-cause mortality, acute MI, and ischemic stroke in insured adults aged 45+ or with known CHD?
A real-world cardiovascular prevention program implemented by a German sickness fund significantly reduced all-cause mortality and a composite of mortality, MI, and stroke, though it did not significantly reduce non-fatal events alone.
Answers are grounded in this paper and cite their sources.
Suggests structured prevention programs may improve real-world cardiovascular outcomes; leaves open whether these benefits persist in.
BACKGROUND: Cardiovascular disease is the leading cause of morbidity and mortality in the developed world. To reduce this burden of disease, a German sickness fund ('Siemens-Betriebskrankenkasse', SBK) initiated the prevention programme 'KardioPro' including primary (risk factor reduction) and secondary (screening) prevention and guideline-based treatment. The aim of this study was to assess the effectiveness of 'KardioPro' as it is implemented in the real world. METHODS: The study is based on sickness fund routine data. The control group was selected from non-participants via propensity score matching. Study analysis was based on time-to-event analysis via Cox proportional hazards regression with the endpoint 'all-cause mortality, acute myocardial infarction (MI) and ischemic stroke (1)', 'all-cause mortality (2)' and 'non-fatal acute MI and ischemic stroke (3)'. RESULTS: A total of 26,202 insurants were included, 13,101 participants and 13,101 control subjects. 'KardioPro' enrollment was associated with risk reductions of 23.5% (95% confidence interval (CI) 13.0-32.7%) (1), 41.7% (95% CI 30.2-51.2%) (2) and 3.5% (hazard ratio 0.965, 95% CI 0.811-1.148) (3). This corresponds to an absolute risk reduction of 0.29% (1), 0.31% (2) and 0.03% (3) per year. CONCLUSION: The prevention programme initiated by a German statutory sickness fund appears to be effective with regard to all-cause mortality. The non-significant reduction in non-fatal events might result from a shift from fatal to non-fatal events.
No takes yet. Share an insight, caveat, or question.
Witt et al. (2014) conducted a cohort in Cardiovascular disease prevention (n=26,202). KardioPro cardiovascular prevention programme vs. Standard care (propensity score matched non-participants) was evaluated on All-cause mortality, acute myocardial infarction, and ischemic stroke (HR 0.765, 95% CI 0.673-0.870, p=<0.0001). The KardioPro cardiovascular prevention programme reduced the combined risk of all-cause mortality, acute myocardial infarction, and ischemic stroke by 23.5% compared to standard care.
Synapse has enriched 10 related papers. Consider them for comparative context: